BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11227737)

  • 1. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G
    J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland.
    Muccioli G; Papotti M; Locatelli V; Ghigo E; Deghenghi R
    J Endocrinol Invest; 2001 Mar; 24(3):RC7-9. PubMed ID: 11314756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.
    Cassoni P; Papotti M; Ghè C; Catapano F; Sapino A; Graziani A; Deghenghi R; Reissmann T; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1738-45. PubMed ID: 11297611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretagogue binding sites in peripheral human tissues.
    Papotti M; Ghè C; Cassoni P; Catapano F; Deghenghi R; Ghigo E; Muccioli G
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3803-7. PubMed ID: 11061542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G; Locatelli V
    Endocrine; 2001 Feb; 14(1):29-33. PubMed ID: 11322499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
    Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
    J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin, cortistatin, ghrelin and glucose metabolism.
    Gauna C; van der Lely AJ
    J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
    Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
    J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
    Ghè C; Cassoni P; Catapano F; Marrocco T; Deghenghi R; Ghigo E; Muccioli G; Papotti M
    Endocrinology; 2002 Feb; 143(2):484-91. PubMed ID: 11796502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
    Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
    Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.
    Pettersson I; Muccioli G; Granata R; Deghenghi R; Ghigo E; Ohlsson C; Isgaard J
    J Endocrinol; 2002 Oct; 175(1):201-9. PubMed ID: 12379504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of binding of targeted analogs of somatostatin carrying cytotoxic radicals or radionuclides to growth hormone secretagogue receptors on human myocardium.
    Halmos G; Schally AV; Comaru-Schally AM; Nagy A; Irimpen A
    Life Sci; 2003 Apr; 72(23):2669-74. PubMed ID: 12672512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
    Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
    J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue.
    Cassoni P; Papotti M; Catapano F; Ghè C; Deghenghi R; Ghigo E; Muccioli G
    J Endocrinol; 2000 Apr; 165(1):139-46. PubMed ID: 10750044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
    Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
    Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
    Korbonits M; Bustin SA; Kojima M; Jordan S; Adams EF; Lowe DG; Kangawa K; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.